TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
253,925
|
284,385
|
385,429 |
Financial expenses |
15
|
232
|
390 |
Earnings before taxes |
12,192
|
9,564
|
17,583 |
Total assets |
210,748
|
198,402
|
216,560 |
Current assets |
210,567
|
198,142
|
216,220 |
Current liabilities |
37,593
|
34,740
|
60,348 |
Equity capital |
173,155
|
163,662
|
156,212 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
26
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.2%
|
82.5%
|
72.1% |
Turnover per employee |
10,938
|
20,286 | |
Profit as a percentage of turnover |
4.8%
|
3.4%
|
4.6% |
Return on assets (ROA) |
5.8%
|
4.9%
|
8.3% |
Current ratio |
560.1%
|
570.4%
|
358.3% |
Return on equity (ROE) |
7.0%
|
5.8%
|
11.3% |
Change turnover |
-30,460
|
-101,044
|
-88,011 |
Change turnover % |
-11%
|
-26%
|
-19% |
Chg. No. of employees |
7
|
2 | |
Chg. No. of employees % |
37%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.